About the Editor
Antonello Mai is a Full Professor of Medicinal Chemistry at the Faculty of
Pharmacy and Medicine, Sapienza University of Rome, since 2011. He completed
his Pharmacy degree in 1984, and his PhD in Medicinal Chemistry and Pharmaceutical Sciences in 1992, both at Sapienza. In 1998 he was appointed as Associate
Professor of Medicinal Chemistry at Sapienza’s Faculty of Pharmacy. From 2012 to
2018, he was the coordinator of the PhD course in Pharmaceutical Science, and from
2013 to 2019, he was President of the Degree Course in Pharmaceutical Chemistry
and Technologies.
From 2004 to 2009, Prof. Mai was a member of the Executive Committee of the
Medicinal Chemistry Division of the Italian Chemical Society, and from 2009 to
2014, he was a member of the Scientific Committee of the European School of
Medicinal Chemistry. He is an Editor of the journal ChemMedChem (Wiley),
Regional Editor of Mini Reviews in Medicinal Chemistry and Medicinal Chemistry
(Bentham), and Associate Editor of Clinical Epigenetics (Springer) and the Journal
of Enzyme Inhibition and Medicinal Chemistry (Taylor and Francis).
His career has largely focused on the synthesis of new potential bioactive
compounds, particularly in the field of epigenetics (since 1999: inhibitors of
HDACs, HATs, sirtuins, PRMTs, HKMTs, KDMs, and DNMTs). Prof. Mai is the
author of more than 280 publications in high-impact international journals [h-index
= 52] and three book chapters.
ix
Antonello Mai is a Full Professor of Medicinal Chemistry at the Faculty of
Pharmacy and Medicine, Sapienza University of Rome, since 2011. He completed
his Pharmacy degree in 1984, and his PhD in Medicinal Chemistry and Pharmaceutical Sciences in 1992, both at Sapienza. In 1998 he was appointed as Associate
Professor of Medicinal Chemistry at Sapienza’s Faculty of Pharmacy. From 2012 to
2018, he was the coordinator of the PhD course in Pharmaceutical Science, and from
2013 to 2019, he was President of the Degree Course in Pharmaceutical Chemistry
and Technologies.
From 2004 to 2009, Prof. Mai was a member of the Executive Committee of the
Medicinal Chemistry Division of the Italian Chemical Society, and from 2009 to
2014, he was a member of the Scientific Committee of the European School of
Medicinal Chemistry. He is an Editor of the journal ChemMedChem (Wiley),
Regional Editor of Mini Reviews in Medicinal Chemistry and Medicinal Chemistry
(Bentham), and Associate Editor of Clinical Epigenetics (Springer) and the Journal
of Enzyme Inhibition and Medicinal Chemistry (Taylor and Francis).
His career has largely focused on the synthesis of new potential bioactive
compounds, particularly in the field of epigenetics (since 1999: inhibitors of
HDACs, HATs, sirtuins, PRMTs, HKMTs, KDMs, and DNMTs). Prof. Mai is the
author of more than 280 publications in high-impact international journals [h-index
= 52] and three book chapters.
ix